Meyka AI API is live for developers.Start building.
Advertisement
Smith & Nephew plc

Smith & Nephew plc (SNN) Stock Overview

Explore Smith & Nephew plc’s financial performance, market position, analyst ratings, and future outlook.

SNNNYSE
HealthcareMedical - Devices
$30.61
$0.24(0.78%)
U.S. Market opens in 54h 56m
Advertisement

Smith & Nephew plc (SNN)

Meyka AI Score

Z

Key Financials

Market Cap13B
P/E Ratio21.17
EPS (TTM)$1.43
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$30.52
3 Months$37.68
1 Year Target$38.61

SNN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Smith & Nephew plc (SNN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.62, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $38.61.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.17 and a market capitalization of 13B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.78%
5-Day Change
2.41%
1-Month Change
-2.24%
3-Month Change
-12.17%
6-Month Change
-8.57%
Year-to-Date (YTD) Change
-6.71%
1-Year Change
1.02%
3-Year Change
1.09%
5-Year Change
-26.19%
All-Time (Max) Change
271.03%

Contact Information

44 1923 477 100
Building 5, Watford, NaN, WD18 8YE

Company Facts

17,349 Employees
IPO DateNov 16, 1999
CountryGB
Actively Trading

Frequently Asked Questions